Associazione Nazionale Medici Cardiologi Ospedalieri

www.anmco.it

CONGRESS ABSTRACT

CONGRESS ABSTRACT

Categorie
Safety and Efficacy of Evolocumab in patients with acute coronary syndrome underwent to Coronary Artery Bypass Graft: a comparative retrospective analysis
Anno:
2024
Background. In-hospital reduction of low-density lipoprotein cholesterol (LDL-C) levels following the acute coronary syndrome (ACS) is recommended in the current clinical guidelines. However, the efficacy of proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors (Evolocumab) in these patients undergoing surgical coronary revascularization has not been demonstrated. Methods. From January 2022…
Leggi di più
DIFFERENT INTRAOPERATIVE TRANSIT TIME FLOW MEASUREMENT DOES NOT AFFECT EARLY OUTCOME IN FEMALE AND MALE GENDER AFTER CABG
Anno:
2024
Background: Intraoperative transit time flow measurement (TTFM) of left internal thoracic (L-ITA) and saphenous vein (SV) grafts (SVG) can improve graft patency and, consequently, clinical outcome in patients undergoing coronary artery bypass grafting (CABG). We have investigate if there were differences in female and male gender on TTFM -flow…
Leggi di più

A.N.M.C.O. – Via La Marmora 36, 50121 Firenze (Italy) – Partita I.V.A. 05469530488 – Codice Fiscale 01301130488 – Privacy
www.anmco.it | segreteria@anmco.it

Cookie Policy Privacy Policy

Seguici su

Facebook Twitter Youtube Linkedin Instagram Telegram